Cue Biopharma, Inc. (CUE) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cue Biopharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.533 Good day and welcome to the QBioPharm second quarter 2024 earnings 00:00:04.533 -- 00:00:07.855 call. All participants will be in a listen-only mode. 00:00:07.855 -- 00:00:11.338 Should you need assistance, please signal conference specialists by pressing the star 00:00:11.338 -- 00:00:15.781 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:15.781 -- 00:00:21.226 questions. To ask a question, you may press star then one on your touchtone phone. 00:00:21.226 -- 00:00:24.608 And to withdraw your question, please press star then two. 00:00:24.608 -- 00:00:28.524 Please note this event is being recorded. I would now like to turn the conference over 00:00:28.524 -- 00:00:31.346 to our Chief Executive Officer, Mr. Dan Paceri. 00:00:31.346 -- 00:00:32.207 Please go ahead, sir. 00:00:32.207 -- 00:00:33.648 Okay, 00:00:33.648 -- 00:00:38.973 thank you, and good afternoon, everyone. As a reminder, this presentation and discussion 00:00:38.973 -- 00:00:44.758 is being recorded and will be available on our website for the next 30 days. 00:00:44.758 -- 00:00:49.782 Also, please be aware that the slides accompanying today's update may be advanced directly 00:00:49.782 -- 00:00:54.887 by those listening in, and we will notify you on what slide we're on 00:00:54.887 -- 00:00:59.141 throughout the presentation. Joining me on today's call is Dr. 00:00:59.141 -- 00:01:02.843 Anish Suri, our President and Chief Scientific Officer, and Dr. 00:01:02.843 -- 00:01:06.384 Matteo Levassetti, our Chief Medical Officer. 00:01:06.384 -- 00:01:11.587 Shown here on slide two, this presentation and overview may contain some 00:01:11.587 -- 00:01:16.009 forward-looking statements, and any forward-looking statements made d...